Shanghai Shyndec Pharmaceutical Co., Ltd. (600420) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Shanghai Shyndec Pharmaceutical Co., Ltd.

Why is Shanghai Shyndec Pharmaceutical Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 12.64%

The company has been able to generate a Return on Capital Employed (avg) of 12.64% signifying low profitability per unit of total capital (equity and debt)

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of -7.58% and Operating profit at -6.95% over the last 5 years
The company is Net-Debt Free
The company has been able to generate a Return on Equity (avg) of 10.07% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of -7.58% and Operating profit at -6.95% over the last 5 years

With a fall in EPS of -0.87%, the company declared Very Negative results in Jun 26

The company has declared negative results for the last 5 consecutive quarters
NET PROFIT(HY) At CNY 275.59 MM has Grown at -58.99%
OPERATING CASH FLOW(Y) Lowest at CNY 1,136.03 MM
ROCE(HY) Lowest at 3.97%

With ROE of 6.54%, it has a attractive valuation with a 0.75 Price to Book Value

Over the past year, while the stock has generated a return of -22.93%, its profits have fallen by -31.5%
At the current price, the company has a high dividend yield of 6.4

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Shanghai Shyndec Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shanghai Shyndec Pharmaceutical Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Shanghai Shyndec Pharmaceutical Co., Ltd.

-23.08%

-1.14

23.01%

China Shanghai Composite

3.23%

0.23

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-7.58%

EBIT Growth (5y)

-6.95%

EBIT to Interest (avg)

64.64

Debt to EBITDA (avg)

0.13

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

0.72

Tax Ratio

14.83%

Dividend Payout Ratio

42.73%

Pledged Shares

Institutional Holding

ROCE (avg)

11.57%

ROE (avg)

10.07%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.75

EV to EBIT

9.74

EV to EBITDA

5.87

EV to Capital Employed

0.70

EV to Sales

0.91

PEG Ratio

Dividend Yield

6.43%

ROCE (Latest)

7.15%

ROE (Latest)

6.54%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

DIVIDEND PAYOUT RATIO(Y)

Highest at 48.88%

-24What is not working for the Company

NET PROFIT(HY)

At CNY 275.59 MM has Grown at -58.99%

OPERATING CASH FLOW(Y)

Lowest at CNY 1,136.03 MM

ROCE(HY)

Lowest at 3.97%

RAW MATERIAL COST(Y)

Grown by 18.48% (YoY

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.64 times

NET SALES(Q)

Lowest at CNY 1,875.78 MM

Here's what is working for Shanghai Shyndec Pharmaceutical Co., Ltd.

Dividend Payout Ratio

Highest at 48.88%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Here's what is not working for Shanghai Shyndec Pharmaceutical Co., Ltd.

Net Profit

At CNY 275.59 MM has Grown at -58.99%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 1,136.03 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

At CNY 1,875.78 MM has Fallen at -14.94%

over average net sales of the previous four periods of CNY 2,205.15 MM

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Net Sales

Lowest at CNY 1,875.78 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Debtors Turnover Ratio

Lowest at 4.64 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Raw Material Cost

Grown by 18.48% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales